40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
29.44%
Similar revenue growth to CRK's 37.69%. Walter Schloss would investigate if similar growth reflects similar quality.
29.10%
Cost growth above 1.5x CRK's 17.55%. Michael Burry would check for structural cost disadvantages.
29.73%
Gross profit growth 50-75% of CRK's 43.45%. Martin Whitman would scrutinize competitive position.
0.23%
Margin expansion below 50% of CRK's 4.18%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.84%
Other expenses growth 50-75% of CRK's 10.88%. Bruce Berkowitz would examine cost efficiency.
3.43%
Operating expenses growth 50-75% of CRK's 5.34%. Bruce Berkowitz would examine efficiency.
19.12%
Total costs growth above 1.5x CRK's 10.35%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
5.84%
D&A growth 50-75% of CRK's 10.90%. Bruce Berkowitz would examine asset strategy.
35.49%
EBITDA growth 50-75% of CRK's 48.60%. Martin Whitman would scrutinize operations.
-5.00%
EBITDA margin decline while CRK shows 35.55% growth. Joel Greenblatt would examine position.
53.71%
Similar operating income growth to CRK's 70.10%. Walter Schloss would investigate industry trends.
18.75%
Similar operating margin growth to CRK's 23.53%. Walter Schloss would investigate industry trends.
212.00%
Other expenses growth above 1.5x CRK's 0.97%. Michael Burry would check for concerning trends.
134.86%
Pre-tax income growth 1.25-1.5x CRK's 107.60%. Bruce Berkowitz would examine sustainability.
81.45%
Pre-tax margin growth exceeding 1.5x CRK's 50.77%. David Dodd would verify competitive advantages.
99.09%
Similar tax expense growth to CRK's 107.60%. Walter Schloss would investigate patterns.
206.43%
Net income growth exceeding 1.5x CRK's 119.40%. David Dodd would verify competitive advantages.
136.74%
Net margin growth exceeding 1.5x CRK's 59.34%. David Dodd would verify competitive advantages.
285.71%
EPS growth exceeding 1.5x CRK's 110.53%. David Dodd would verify competitive advantages.
280.22%
Diluted EPS growth exceeding 1.5x CRK's 81.29%. David Dodd would verify competitive advantages.
-6.66%
Share count reduction while CRK shows 0.21% change. Joel Greenblatt would examine strategy.
-5.30%
Diluted share reduction while CRK shows 19.20% change. Joel Greenblatt would examine strategy.